<VariationArchive VariationID="285045" VariationName="NM_000448.3(RAG1):c.256_257del (p.Lys86fs)" VariationType="Deletion" Accession="VCV000285045" Version="19" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="8" DateLastUpdated="2024-06-17" DateCreated="2017-12-26" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="269282" VariationID="285045">
      <GeneList>
        <Gene Symbol="RAG1" FullName="recombination activating 1" GeneID="5896" HGNC_ID="HGNC:9831" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="36510353" stop="36579762" display_start="36510353" display_stop="36579762" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="36589562" stop="36601311" display_start="36589562" display_stop="36601311" Strand="+" />
          </Location>
          <OMIM>179615</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000448.3(RAG1):c.256_257del (p.Lys86fs)</Name>
      <CanonicalSPDI>NC_000011.10:36573559:AA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="36573560" stop="36573561" display_start="36573560" display_stop="36573561" variantLength="2" positionVCF="36573559" referenceAlleleVCF="TAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="36595110" stop="36595111" display_start="36595110" display_stop="36595111" variantLength="2" positionVCF="36595109" referenceAlleleVCF="TAA" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_000448.3(RAG1):c.256_257del</Name>
        <Name>p.Lys86fs</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_98" sequenceAccession="LRG_98">
            <Expression>LRG_98:g.10548_10549del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.36595110_36595111del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.36595110_36595111del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.36573560_36573561del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.36573560_36573561del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007528.1" sequenceAccession="NG_007528" sequenceVersion="1" change="g.10548_10549del">
            <Expression>NG_007528.1:g.10548_10549del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000448.3" sequenceAccession="NM_000448" sequenceVersion="3" change="c.256_257del" MANESelect="true">
            <Expression>NM_000448.3:c.256_257del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000439.2" sequenceAccession="NP_000439" sequenceVersion="2" change="p.Lys86fs">
            <Expression>NP_000439.2:p.Lys86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377277.1" sequenceAccession="NM_001377277" sequenceVersion="1" change="c.256_257del">
            <Expression>NM_001377277.1:c.256_257del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364206.1" sequenceAccession="NP_001364206" sequenceVersion="1" change="p.Lys86fs">
            <Expression>NP_001364206.1:p.Lys86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377278.1" sequenceAccession="NM_001377278" sequenceVersion="1" change="c.256_257del">
            <Expression>NM_001377278.1:c.256_257del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364207.1" sequenceAccession="NP_001364207" sequenceVersion="1" change="p.Lys86fs">
            <Expression>NP_001364207.1:p.Lys86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377279.1" sequenceAccession="NM_001377279" sequenceVersion="1" change="c.256_257del">
            <Expression>NM_001377279.1:c.256_257del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364208.1" sequenceAccession="NP_001364208" sequenceVersion="1" change="p.Lys86fs">
            <Expression>NP_001364208.1:p.Lys86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377280.1" sequenceAccession="NM_001377280" sequenceVersion="1" change="c.256_257del">
            <Expression>NM_001377280.1:c.256_257del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364209.1" sequenceAccession="NP_001364209" sequenceVersion="1" change="p.Lys86fs">
            <Expression>NP_001364209.1:p.Lys86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000448.2" sequenceAccession="NM_000448" sequenceVersion="2" change="c.256_257delAA">
            <Expression>NM_000448.2:c.256_257delAA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA5949936" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="179615.0013" DB="OMIM" />
        <XRef Type="rs" ID="772962160" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00004" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00005" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00005" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00016" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000448.3(RAG1):c.256_257del (p.Lys86fs) AND multiple conditions" Accession="RCV000282657" Version="8">
        <ClassifiedConditionList TraitSetID="22355">
          <ClassifiedCondition DB="MedGen" ID="C2673536">Combined immunodeficiency with skin granulomas</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1832322">Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000448.3(RAG1):c.256_257del (p.Lys86fs) AND RAG1-related disorder" Accession="RCV000779060" Version="4">
        <ClassifiedConditionList TraitSetID="47294">
          <ClassifiedCondition>RAG1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000448.3(RAG1):c.256_257del (p.Lys86fs) AND not provided" Accession="RCV000725574" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2018-09-05" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000448.3(RAG1):c.256_257del (p.Lys86fs) AND Combined immunodeficiency due to partial RAG1 deficiency" Accession="RCV002279720" Version="3">
        <ClassifiedConditionList TraitSetID="3579">
          <ClassifiedCondition DB="MedGen" ID="C1835931">Combined immunodeficiency due to partial RAG1 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-27" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000448.3(RAG1):c.256_257del (p.Lys86fs) AND Severe combined immunodeficiency disease" Accession="RCV002222473" Version="1">
        <ClassifiedConditionList TraitSetID="8766">
          <ClassifiedCondition DB="MedGen" ID="C0085110">Severe combined immunodeficiency disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000448.3(RAG1):c.256_257del (p.Lys86fs) AND Histiocytic medullary reticulosis" Accession="RCV002279719" Version="1">
        <ClassifiedConditionList TraitSetID="1283">
          <ClassifiedCondition DB="MedGen" ID="C2700553">Histiocytic medullary reticulosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000448.3(RAG1):c.256_257del (p.Lys86fs) AND Recombinase activating gene 1 deficiency" Accession="RCV003401250" Version="1">
        <ClassifiedConditionList TraitSetID="88497">
          <ClassifiedCondition DB="MedGen" ID="CN375631">Recombinase activating gene 1 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2023-11-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-14" NumberOfSubmissions="9" NumberOfSubmitters="8" DateCreated="2017-12-26" MostRecentSubmission="2024-06-17">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10891452</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11121059</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11313270</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16276422</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17572155</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22424479</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23085344</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23122631</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24290284</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24418478</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25516070</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26457731</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27301863</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9630231</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=RAG1</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/e2029994-f2fc-46df-8931-f8afe1e193ef</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1283" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5672" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Reticuloendotheliosis familial with eosinophilia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency with hypereosinophilia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Histiocytic medullary reticulosis</ElementValue>
                <XRef ID="Histiocytic+medullary+reticulosis/8555" DB="Genetic Alliance" />
                <XRef ID="307650006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Omenn syndrome</ElementValue>
                <XRef ID="MONDO:0011338" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8198" />
                <XRef ID="8198" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="39041" DB="Orphanet" />
              <XRef ID="C2700553" DB="MedGen" />
              <XRef ID="MONDO:0011338" DB="MONDO" />
              <XRef Type="MIM" ID="603554" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="88497" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="46006" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Recombinase activating gene 1 deficiency</ElementValue>
                <XRef ID="MONDO:0000572" DB="MONDO" />
              </Name>
              <XRef ID="CN375631" DB="MedGen" />
              <XRef ID="MONDO:0000572" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="47294" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="41744" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RAG1-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RAG1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">RAG1-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="8766" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="6210" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Bubble boy disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe Combined Immune Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe combined immunodeficiency disease</ElementValue>
                <XRef ID="31323000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency</ElementValue>
                <XRef ID="HP:0004430" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0015974" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SCID</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">X-Linked or Autosomal recessive</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7628" />
                <XRef ID="7628" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/SCID.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Severe Combined Immunodeficiency (SCID) and Conditions Associated with T Cell Lymphopenia, 2012</CitationText>
              </Citation>
              <XRef ID="183660" DB="Orphanet" />
              <XRef ID="C0085110" DB="MedGen" />
              <XRef ID="D016511" DB="MeSH" />
              <XRef ID="MONDO:0015974" DB="MONDO" />
              <XRef Type="primary" ID="HP:0004430" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="22355" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="828" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Combined cellular and humoral immune defects with granulomas</ElementValue>
                <XRef ID="Combined+cellular+and+humoral+immune+defects+with+granulomas/8008" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Combined immunodeficiency with skin granulomas</ElementValue>
                <XRef ID="MONDO:0009306" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CCHIDG</ElementValue>
                <XRef Type="MIM" ID="233650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13587" />
                <XRef ID="13587" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="157949" DB="Orphanet" />
              <XRef ID="C2673536" DB="MedGen" />
              <XRef ID="MONDO:0009306" DB="MONDO" />
              <XRef Type="MIM" ID="233650" DB="OMIM" />
            </Trait>
            <Trait ID="5906" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Severe immunodeficiency, autosomal recessive, T-cell negative, B-cell negative, NK cell-positive</ElementValue>
                <XRef ID="Severe+immunodeficiency%2C+autosomal+recessive%2C+T-cell+negative%2C+B-cell+negative%2C+NK+cell-positive/6530" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID, AR, T-cell negative, B-cell negative, NK cell-positive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive</ElementValue>
                <XRef ID="MONDO:0011086" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency due to complete RAG1/2 deficiency</ElementValue>
                <XRef ID="331206" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE</ElementValue>
                <XRef Type="MIM" ID="601457" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10339" />
                <XRef ID="10339" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="331206" DB="Orphanet" />
              <XRef ID="C1832322" DB="MedGen" />
              <XRef ID="MONDO:0011086" DB="MONDO" />
              <XRef Type="MIM" ID="601457" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3579" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="107" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Combined immunodeficiency due to partial RAG1 deficiency</ElementValue>
                <XRef ID="MONDO:0012359" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity</ElementValue>
                <XRef ID="Alpha-beta+T-cell+lymphopenia+with+gamma-delta+T-cell+expansion%2C+severe+cytomegalovirus+infection%2C+and+autoimmunity/7672" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13712" />
                <XRef ID="13712" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="231154" DB="Orphanet" />
              <XRef ID="C1835931" DB="MedGen" />
              <XRef ID="MONDO:0012359" DB="MONDO" />
              <XRef Type="MIM" ID="609889" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="34282" SubmissionDate="2013-02-05" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="179615.0013_ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY" title="RAG1, 2-BP DEL, 368AA_ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY" />
        <ClinVarAccession Accession="SCV000034282" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Villa et al. (1998) found a deletion of 2 nucleotides of RAG1 cDNA in heterozygous state in a patient with Omenn syndrome (603554). This mutation results in a truncated protein.</Attribute>
              <Citation>
                <ID Source="PubMed">9630231</ID>
              </Citation>
              <XRef DB="OMIM" ID="603554" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Santagata et al. (2000) demonstrated that a 2-bp deletion (AA) at nucleotides 368 and 369 results in a frameshift at proline-85 and addition of 32 amino acids before a stop. In 1 patient the deletion was combined in compound heterozygous state with the D429G missense mutation (179615.0009); in another patient it was combined with the E722K (179615.0001) missense mutation. In yet another patient the 2-bp deletion was present in homozygous state.</Attribute>
              <Citation>
                <ID Source="PubMed">11121059</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">De Villartay et al. (2005) identified the RAG1 368AA deletion in homozygous state in a Turkish child of consanguineous parents who presented with severe, persistent cytomegalovirus infection, anti-red blood cell antibody-induced anemia, a high percentage of gamma/delta T cells, and a low percentage of alpha/beta T cells (609889).</Attribute>
              <Citation>
                <ID Source="PubMed">16276422</ID>
              </Citation>
              <XRef DB="OMIM" ID="609889" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAG1" />
          </GeneList>
          <Name>RAG1, 2-BP DEL, 368AA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 368AA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="179615.0013" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="34281" SubmissionDate="2013-02-05" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="179615.0013_OMENN SYNDROME" title="RAG1, 2-BP DEL, 368AA_OMENN SYNDROME" />
        <ClinVarAccession Accession="SCV000034281" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Villa et al. (1998) found a deletion of 2 nucleotides of RAG1 cDNA in heterozygous state in a patient with Omenn syndrome (603554). This mutation results in a truncated protein.</Attribute>
              <Citation>
                <ID Source="PubMed">9630231</ID>
              </Citation>
              <XRef DB="OMIM" ID="603554" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Santagata et al. (2000) demonstrated that a 2-bp deletion (AA) at nucleotides 368 and 369 results in a frameshift at proline-85 and addition of 32 amino acids before a stop. In 1 patient the deletion was combined in compound heterozygous state with the D429G missense mutation (179615.0009); in another patient it was combined with the E722K (179615.0001) missense mutation. In yet another patient the 2-bp deletion was present in homozygous state.</Attribute>
              <Citation>
                <ID Source="PubMed">11121059</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">De Villartay et al. (2005) identified the RAG1 368AA deletion in homozygous state in a Turkish child of consanguineous parents who presented with severe, persistent cytomegalovirus infection, anti-red blood cell antibody-induced anemia, a high percentage of gamma/delta T cells, and a low percentage of alpha/beta T cells (609889).</Attribute>
              <Citation>
                <ID Source="PubMed">16276422</ID>
              </Citation>
              <XRef DB="OMIM" ID="609889" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAG1" />
          </GeneList>
          <Name>RAG1, 2-BP DEL, 368AA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 368AA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="179615.0013" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OMENN SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="651415" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="39421_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000337892" DateUpdated="2018-12-15" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23122631</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24418478</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAG1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="-" referenceAllele="AA" start="36595110" stop="36595111" variantLength="2" />
            <GeneLocation>NM_000448.2:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD982919" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=RAG1</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790598" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="885565" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915526" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24290284</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25516070</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23122631</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26457731</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27301863</ID>
          </Citation>
          <Comment>The RAG1 c.256_257delAA (p.Lys86ValfsTer33) variant is a frameshift variant that is predicted to result in premature termination of the protein. The p.Lys86ValfsTer33 variant has been reported in five studies in which it is found in a total of 14 individuals with RAG1-related disorders, including in eight in a homozygous state, five in a compound heterozygous state, and one in a heterozygous state (Abraham et al. 2013; Lee et al. 2014; Buchbinder et al. 2015; Walter et al. 2015; Brauer et al. 2016). Homozygous individuals included six with severe combined immune deficiency (SCID) and two with Omenn syndrome (OS); compound heterozygous individuals included two with OS, one with common variable immunodeficiency disorder (CVID), two with combined immune deficiency with granuloma and/or autoimmunity (CID-G/A); the heterozygote had an unspecified immunodeficiency. Control data are unavailable for this variant, which is reported at a frequency of 0.00008 in the European (non-Finnish) population of the Exome Aggregation Consortium. The p.Lys86ValfsTer33 variant protein was found to have approximately three percent of wild type RAG1 recombinase activity when analyzed in pro-B cells that were deficient for wild type RAG1 (Abraham et al. 2013; Buchbinder et al. 2015; Brauer et al. 2016). Based on the evidence and potential impact of frameshift variants, the p.Lys86ValfsTer33 variant is classified as pathogenic for RAG1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAG1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="T" referenceAllele="TAA" start="36595109" stop="36595111" variantLength="3" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000448.2:c.256_257delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">RAG1-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1816539" SubmissionDate="2019-05-08" DateLastUpdated="2019-07-25" DateCreated="2019-07-25">
        <ClinVarSubmissionID localKey="NM_000448.2:c.256_257del|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000927916" DateUpdated="2019-07-25" DateCreated="2019-07-25" Type="SCV" Version="1" SubmitterName="Blueprint Genetics" OrgID="500188" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Blueprint Genetics Variant Classification Scheme</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8okxtmpf/blueprint_genetics_variant_classification_scheme.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000448.2:c.256_257del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment>Patient analyzed with Severe Combined Immunodeficiency Panel</Comment>
        <SubmissionNameList>
          <SubmissionName>Blueprint Genetics 4/2019</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1230617" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="761237|MedGen:C2673536;C1832322" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000638115" DateUpdated="2024-02-28" DateCreated="2017-12-26" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9630231</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22424479</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23085344</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24290284</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25516070</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10891452</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24418478</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25516070</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys86Valfs*33) in the RAG1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 958 amino acid(s) of the RAG1 protein. This variant is present in population databases (rs772962160, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with Omenn syndrome or severe combined immunodeficiency (PMID: 9630231, 22424479, 23085344, 24290284, 25516070). ClinVar contains an entry for this variant (Variation ID: 285045). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects RAG1 function (PMID: 10891452, 24418478, 25516070). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAG1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.36595110_36595111del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2673536" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1832322" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4891222" SubmissionDate="2022-04-19" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000448.2:c.256_257delAA|MedGen:CN239264" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002500598" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17572155</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11121059</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11313270</ID>
          </Citation>
          <Comment>Variant summary: RAG1 c.256_257delAA (p.Lys86ValfsX33) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 1.2e-05 in 251098 control chromosomes. c.256_257delAA has been reported in the literature in multiple individuals affected with Severe Combined Immunodeficiency Syndrome/Omenn Syndrome. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAG1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000448.2:c.256_257delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN239264" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11350627</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="7682814" SubmissionDate="2023-11-14" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="e2029994-f2fc-46df-8931-f8afe1e193ef" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004102807" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen" OrgID="509310" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-14">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/e2029994-f2fc-46df-8931-f8afe1e193ef</URL>
          </Citation>
          <Comment>The c.256_257del (p.Lys86ValfsTer33) variant in RAG1 is a frameshift variant that may cause a premature stop codon that is predicted to escape nonsense-mediated decay. The variant causes a truncation of a functionally important region (removes amino acids 86-1011) of the RAG1 protein. The variants also cause the usage of an alternative in-frame start codon (Met183), but the alternatively transcribed protein has decreased recombination activity and mislocalization in cells (PMIDs 11121059, 27301863). So the variant may cause protein loss-of-function (PVS1; PMIDs 11121059, 27301863). The filtering allele frequency based on the European (non-Finnish) population (upper bound of 95% CI of 6/128846 observed alleles) is 0.000007030 in gnomAD v2.1.1 which is below the SCID-VCEP threshold (&lt;0.000102) and therefore meets this criterion (PM2_Supporting). The in vitro recombination assay shows that the p.Lys86ValfsTer33 variant in RAG1 causes a decrease of recombination activity to below 25%, indicating that the variant impacts the protein function. (PS3_Moderate; PMID 24290284). One homozygous individual with OS. One homozygous individual with SCID. 1pt for PM3. (PMID 11121059, patient OS8; PMID 32655540, patient #32). PM3 met. One patient with this variant was diagnosed with SCID (0.5pt). The patient showed T-B-NK+ lymphocyte profile (0.5pt). 1pt in total, PP4 met. (PMID 32655540, proband #32) In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: PVS1, PM2_supporting, PM3_moderate, PS3_moderate, and PP4_supporting. (VCEP specifications version 1).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen SCID ACMG Specifications RAG1 V1.0.0</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/aotv5hab/clingen_scid_acmg_specifications_rag1_v1.0.0_1_.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAG1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000448.3(RAG1):c.256_257del</Name>
            <Name>p.Lys86fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.10:g.36573560_36573561del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0000572" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13972469</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7857421" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000448.3:c.256_257del|OMIM:609889" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004200458" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000448.3:c.256_257del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609889" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="651415" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7857421" TraitType="Disease" MappingType="XRef" MappingValue="609889" MappingRef="OMIM">
        <MedGen CUI="C1835931" Name="Combined immunodeficiency due to partial RAG1 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1230617" TraitType="Disease" MappingType="XRef" MappingValue="C2673536" MappingRef="MedGen">
        <MedGen CUI="C2673536" Name="Combined immunodeficiency with skin granulomas" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="34281" TraitType="Disease" MappingType="Name" MappingValue="OMENN SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C2700553" Name="Histiocytic medullary reticulosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790598" TraitType="Disease" MappingType="Name" MappingValue="RAG1-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="RAG1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1230617" TraitType="Disease" MappingType="XRef" MappingValue="C1832322" MappingRef="MedGen">
        <MedGen CUI="C1832322" Name="Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="34282" TraitType="Disease" MappingType="Name" MappingValue="ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY" MappingRef="Alternate">
        <MedGen CUI="C1835931" Name="Combined immunodeficiency due to partial RAG1 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4891222" TraitType="Disease" MappingType="XRef" MappingValue="CN239264" MappingRef="MedGen">
        <MedGen CUI="C0085110" Name="Severe combined immunodeficiency disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1816539" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7682814" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0000572" MappingRef="MONDO">
        <MedGen CUI="CN375631" Name="Recombinase activating gene 1 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

